ICCM SCHEDULE 13G/A: SEC filing

Armistice Capital, LLC

Filed with the SEC on · accession 0001172661-26-005232

ICCM filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Armistice Capital, LLC filed an amended Schedule 13G reporting beneficial ownership of 264,419 ordinary shares of IceCure Medical Ltd., representing 4.99% of the class, as of September 30, 2026. The stock moved +2.7% by the first close after the filing.

Summary of the filing

Armistice Capital, LLC filed an amended Schedule 13G reporting beneficial ownership of 264,419 ordinary shares of IceCure Medical Ltd., representing 4.99% of the class, as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control.

Key details

Ordinary shares beneficially owned$264K
Percent of class beneficially ownedPCT 5
Reporting person / investment managerArmistice Capital, LLC
Direct holder of the reported sharesArmistice Capital Master Fund Ltd.
IssuerIceCure Medical Ltd.
Managing member, armistice capital, llcSteven Boyd

How ICCM stock reacted

Close before

$0.73

Nov 13, 2026

First close after

+2.74%

$0.75

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ICCM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ICCM?

Click here

Frequently asked questions

What did ICCM file with the SEC on Nov 16, 2026?

ICCM filed a SCHEDULE 13G/A (SEC filing). Armistice Capital, LLC filed an amended Schedule 13G reporting beneficial ownership of 264,419 ordinary shares of IceCure Medical Ltd., representing 4.99% of the class, as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ICCM stock react to this filing?

ICCM closed at $0.73 before the filing and $0.75 on Nov 16, 2026 (+2.74%).

Other ICCM SEC filings

Get alerts when ICCM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days